|
HRP20020231A2
(en)
*
|
2002-03-18 |
2003-12-31 |
Pliva D D |
ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
|
|
US5912331A
(en)
*
|
1991-03-15 |
1999-06-15 |
Merck & Co., Inc. |
Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
|
|
US5985844A
(en)
*
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
|
US5189159A
(en)
*
|
1992-04-02 |
1993-02-23 |
Merck & Co., Inc. |
8a-AZA-8a-homoerythromycin cyclic iminoethers
|
|
EP0539223A1
(en)
*
|
1991-10-25 |
1993-04-28 |
Ono Pharmaceutical Co., Ltd. |
Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase
|
|
US5215980A
(en)
*
|
1992-01-17 |
1993-06-01 |
Merck & Co., Inc. |
10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
|
|
US5210235A
(en)
*
|
1992-08-26 |
1993-05-11 |
Merck & Co., Inc. |
Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
|
|
US5332807A
(en)
*
|
1993-04-14 |
1994-07-26 |
Merck & Co., Inc. |
Process of producing 8A- and 9A-azalide antibiotics
|
|
CN1034734C
(zh)
*
|
1993-12-10 |
1997-04-30 |
北京市集才药物研究所 |
一种新的阿齐红霉素结晶及其制备方法
|
|
US5605889A
(en)
|
1994-04-29 |
1997-02-25 |
Pfizer Inc. |
Method of administering azithromycin
|
|
US6068859A
(en)
|
1994-05-06 |
2000-05-30 |
Pfizer Inc. |
Controlled-release dosage forms of Azithromycin
|
|
ES2122905B1
(es)
*
|
1996-07-11 |
1999-11-16 |
Astur Pharma Sa |
Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
|
|
SI1437359T1
(sl)
*
|
1997-10-16 |
2007-06-30 |
Glaxosmithkline Zagreb |
Novi 3,6-hemiketali iz razreda 9a-azalidov
|
|
US6861411B1
(en)
|
1997-12-02 |
2005-03-01 |
Pfizer, Inc. |
Method of treating eye infections with azithromycin
|
|
PT102130A
(pt)
*
|
1998-03-13 |
1999-09-30 |
Hovione Sociedade Quimica S A |
Processo de preparacao de dihidrato de azitromicina
|
|
TW546302B
(en)
*
|
1998-05-08 |
2003-08-11 |
Biochemie Sa |
Improvements in macrolide production
|
|
CA2245398C
(en)
*
|
1998-08-21 |
2002-01-29 |
Apotex Inc. |
Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
|
|
ES2229804T3
(es)
*
|
1998-11-30 |
2005-04-16 |
Teva Pharmaceutical Industries Ltd. |
Etannolato de azitromicina, procedimiento para su fabricacion y composiciones farmaceuticas que lo contienen.
|
|
US7056893B2
(en)
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
ES2302689T3
(es)
*
|
1999-05-18 |
2008-08-01 |
Pfizer Products Inc. |
Nuevas formas cristalinas de un antibiotico macrolido.
|
|
US6703372B1
(en)
*
|
1999-06-29 |
2004-03-09 |
Biochemie S.A. |
Macrolides
|
|
ES2177373B1
(es)
|
1999-11-26 |
2003-11-01 |
Astur Pharma Sa |
Preparacion de azitromicina en su forma no cristalina
|
|
IL150564A0
(en)
*
|
2000-01-04 |
2003-02-12 |
Teva Pharma |
Preparation method of azithromycin dihydrate
|
|
ES2162764B1
(es)
*
|
2000-05-17 |
2003-04-01 |
Ercros Ind Sa |
Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
|
|
US6528492B1
(en)
|
2000-07-25 |
2003-03-04 |
Instituto De Investigacion En Quimica Aplicada S.C. |
Single-step process for preparing 7, 16-deoxy-2-aza-10-0-cladinosil-12-0-desosaminil-4, 5-dihydroxy-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1) hexadeca-1(2)-en-ona and obtaining a new form of 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a
|
|
ES2172417B1
(es)
*
|
2000-07-31 |
2003-09-16 |
Sint Quimica Sa |
Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
|
|
ATE306491T1
(de)
|
2000-08-23 |
2005-10-15 |
Wockhardt Ltd |
Verfahren zur herstellung von wasserfreiem azithromycin
|
|
CN100341886C
(zh)
*
|
2000-11-27 |
2007-10-10 |
桑多斯股份公司 |
大环内酯类化合物的溶剂化物
|
|
AU2002221895A1
(en)
*
|
2000-11-27 |
2002-06-03 |
Biochemie S.A. |
Macrolide solvates
|
|
IN190080B
(en:Method)
*
|
2001-01-29 |
2003-06-07 |
Alembic Ltd |
|
|
KR100491183B1
(ko)
|
2001-03-21 |
2005-05-25 |
한미약품 주식회사 |
아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
|
|
NZ539801A
(en)
*
|
2001-05-22 |
2006-10-27 |
Pfizer Prod Inc |
Crystal forms of azithromycin
|
|
US6861413B2
(en)
|
2001-05-22 |
2005-03-01 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
|
SI1390377T1
(sl)
|
2001-05-22 |
2006-06-30 |
Pfizer Prod Inc |
Nova kristalna oblika azitromicina
|
|
CA2458135A1
(en)
*
|
2001-08-21 |
2003-03-06 |
Pfizer Products Inc. |
Single dose azithromycin for treating respiratory infections
|
|
BR0215175A
(pt)
*
|
2001-12-21 |
2004-12-28 |
Pfizer Prod Inc |
Métodos para a granulação úmida de azitromicina
|
|
NZ532707A
(en)
*
|
2001-12-21 |
2006-07-28 |
Pfizer Prod Inc |
Directly compressible formulations of azithromycin
|
|
AU2003201146B2
(en)
*
|
2002-02-01 |
2008-04-17 |
Pfizer Products Inc. |
Dry granulated formulations of azithromycin
|
|
US7376064B2
(en)
|
2002-02-25 |
2008-05-20 |
Samsung Electronics Co., Ltd. |
Method and apparatus for recording data on optical recording medium
|
|
ITMI20021209A1
(it)
*
|
2002-06-04 |
2003-12-04 |
Chemi Spa |
Processo di preparazione di azitromicina ad elevata purezza
|
|
US6855813B2
(en)
*
|
2002-07-19 |
2005-02-15 |
Alembic Limited |
Process for the preparation of azithromycin monohydrate
|
|
HRP20020614A2
(en)
|
2002-07-22 |
2004-06-30 |
PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. |
Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
|
|
GB2395482A
(en)
*
|
2003-07-03 |
2004-05-26 |
Jubilant Organosys Ltd |
Process for preparing non-hygroscopic azithromycin dihydrate
|
|
US20050013835A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
|
CN1889931A
(zh)
*
|
2003-12-04 |
2007-01-03 |
辉瑞产品公司 |
利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾－冻凝方法
|
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
|
WO2005053656A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
|
|
BRPI0416534A
(pt)
*
|
2003-12-04 |
2007-01-09 |
Pfizer Prod Inc |
composições multiparticuladas com estabilidade melhorada
|
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
|
JP2007513145A
(ja)
*
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
医薬用多微粒子の製造方法
|
|
JP2007513146A
(ja)
*
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
液体系プロセスによるアジスロマイシンマルチパーティキュレート剤形
|
|
RU2260012C1
(ru)
*
|
2004-01-29 |
2005-09-10 |
Открытое акционерное общество "Акционерное курганское общество медицинских препаратов и изделий "Синтез" |
Способ кристаллизации азитромицина дигидрата
|
|
US20060116336A1
(en)
*
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
WO2006011160A1
(en)
|
2004-06-28 |
2006-02-02 |
Alembic Limited |
Process for the preparation of azithromycin monohydrate isopropanol clathrate
|
|
CN1308361C
(zh)
*
|
2004-08-09 |
2007-04-04 |
大连振邦氟涂料股份有限公司 |
乙烯－三氟氯乙烯共聚物的制备方法
|
|
US7683162B2
(en)
*
|
2004-08-30 |
2010-03-23 |
Taro Pharmaceutical Industries Limited |
Process of preparing a crystalline azithromycin monohydrate
|
|
EP1817315A1
(en)
*
|
2004-12-01 |
2007-08-15 |
Teva Gyógyszergyár Zártköruen Muködo Részvenytarsaság |
Processes for producing crystalline macrolides
|
|
WO2006067576A1
(en)
*
|
2004-12-21 |
2006-06-29 |
Pfizer Products Inc. |
Enteric coated azithromycin multiparticulates
|
|
US8524734B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
CN100366686C
(zh)
*
|
2006-01-12 |
2008-02-06 |
济南瑞氟化工科技有限公司 |
一种氟硅超双疏不粘涂料
|
|
US20070281894A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
|
US7704959B2
(en)
|
2006-10-03 |
2010-04-27 |
Dow Pharmaceutical Sciences |
Azithromycin for the treatment of nodular acne
|
|
US20090062220A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched azithromycin
|
|
CN101177441B
(zh)
*
|
2007-12-05 |
2012-05-23 |
浙江耐司康药业有限公司 |
一种稳定的阿奇霉素一水合物结晶的制备方法
|
|
CN101624412B
(zh)
*
|
2008-07-10 |
2012-07-04 |
刘力 |
大环内酯类衍生物及其制备和用途
|
|
LT2344129T
(lt)
|
2008-10-07 |
2018-05-10 |
Horizon Orphan Llc |
Aerozolinės fluorchinolono kompozicijos, skirtos farmakokinetikų pagerinimui
|
|
HRP20201150T8
(hr)
|
2008-10-07 |
2021-06-25 |
Horizon Orphan Llc |
Inhalacija levofloksacina za smanjenje upale pluća
|
|
CN101418026B
(zh)
*
|
2008-10-09 |
2011-05-18 |
南京工业大学 |
一种晶型和粒度可控的阿奇霉素结晶工艺
|
|
CN101787063B
(zh)
*
|
2009-01-23 |
2012-12-19 |
刘力 |
抗感染药物及其制备和用途
|
|
AU2010223233A1
(en)
|
2009-03-13 |
2011-10-06 |
Assistance Publique - Hopitaux De Paris |
Compositions and methods for elimination of Gram-negative bacteria
|
|
CA2938650C
(en)
|
2009-09-04 |
2018-01-09 |
Raptor Pharmaceuticals Inc. |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
|
CN102911219A
(zh)
*
|
2011-08-03 |
2013-02-06 |
山东方明药业集团股份有限公司 |
一种阿齐霉素在水相直接结晶的方法
|
|
CN103159811A
(zh)
*
|
2011-12-10 |
2013-06-19 |
山东方明药业集团股份有限公司 |
一种阿齐霉素中间体9a-脱氧-9a-氮杂-9a-高红霉素A的制备方法
|
|
WO2013088274A1
(en)
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
|
|
CN102417531B
(zh)
*
|
2011-12-20 |
2014-06-11 |
浙江国邦药业有限公司 |
一种阿奇霉素一水合物的制备方法
|